BRIEF published on 10/03/2025 at 14:18, 2 months 1 day ago Edenred Releases Share Capital and Voting Rights Update Edenred Share Capital Voting Rights Financial Report September 2025
REGULATED PRESS RELEASE published on 10/03/2025 at 14:13, 2 months 1 day ago Disclosure of Share Capital and Voting Rights as of September 30, 2025 Edenred discloses share capital and voting rights as of September 30, 2025, in accordance with regulatory requirements Edenred Share Capital Voting Rights Disclosure Regulatory Requirements
BRIEF published on 09/16/2025 at 08:42, 2 months 18 days ago Kelly Richdale Joins Edenred's Board of Directors Edenred Independent Director Board Appointment Kelly Richdale Technology Expert
REGULATED PRESS RELEASE published on 09/16/2025 at 08:37, 2 months 18 days ago Co-option of Kelly Richdale to Edenred's Board of Directors Edenred co-opts Kelly Richdale to its Board of Directors, succeeding Monica Mondardini. Richdale brings tech expertise and operational risk management Edenred Board Of Directors Kelly Richdale Tech Expertise Operational Risk Management
BRIEF published on 09/04/2025 at 12:24, 3 months ago Edenred Reports Share Capital and Voting Rights as of August 31, 2025 Edenred Share Capital Voting Rights Financial Regulations France
REGULATED PRESS RELEASE published on 09/04/2025 at 12:19, 3 months ago Disclosure of Share Capital and Voting Rights as of August 31, 2025 Edenred discloses share capital and voting rights data as per regulatory requirements Edenred Share Capital Voting Rights Disclosure Regulatory Requirements
BRIEF published on 08/05/2025 at 10:48, 3 months 30 days ago Edenred Reports Share Capital and Voting Rights Details for July 2025 Edenred Share Capital Voting Rights Financial Disclosure July 2025
REGULATED PRESS RELEASE published on 08/05/2025 at 10:43, 3 months 30 days ago Disclosure of Share Capital and Voting Rights as of July 31, 2025 Edenred discloses share capital and voting rights as of July 31, 2025, in compliance with French regulations. Details available on edenred.com Edenred Share Capital Voting Rights French Regulations
REGULATED PRESS RELEASE published on 07/23/2025 at 07:00, 4 months 13 days ago Edenred : First-quarter 2025 revenue
BRIEF published on 07/04/2025 at 17:37, 5 months ago Edenred's Half-Year Liquidity Contract Update Edenred Liquidity Contract BNP Paribas Financial Report Market Practice
Published on 12/05/2025 at 02:35, 4 hours 41 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 16 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 11 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 16 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 16 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 46 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 25 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 51 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 1 minute ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 16 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 31 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 32 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
